AIER EYE HOSPITAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.24 CNY | +2.34% |
|
-1.45% | -22.63% |
| Mar. 15 | Hepalink Pharmaceutical Gets Lifeline from Controlling Shareholder | MT |
| Feb. 29 | Nomura Adjusts Aier Eye Hospital Group’s Price Target to 22.14 Yuan From 25.03 Yuan, Keeps at Buy. | MT |
Evolution of the average Target Price on Aier Eye Hospital Group Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
2252e12e410a04.DW5n98sZVbHsmbzDKoeUU0msfFJw98L9mIjTmUFU-4k.QiglnJxfGeWU__GtEvekCTHkNAcnmYuU7dfr9QYOsuF9CiGbmF8P7t3t7Q~575f9ecbe08f49a70fbd5a44b2639fe4
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
12.24
CNY
Average target price
23.26
CNY
Spread / Average Target
+90.04%
High Price Target
31.87
CNY
Spread / Highest target
+160.38%
Low Price Target
18.7
CNY
Spread / Lowest Target
+52.78%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aier Eye Hospital Group Co., Ltd.
| Nomura | |
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- 300015 Stock
- Consensus Aier Eye Hospital Group Co., Ltd.
